{'Year': '2018', 'Month': 'May'}
Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome.
Diabetes is one of the cardinal features of thiamine-responsive megaloblastic anaemia (TRMA) syndrome. Current knowledge of this rare monogenic diabetes subtype is limited. We investigated the genotype, phenotype and response to thiamine (vitamin B<sub>1</sub>) in a cohort of individuals with TRMA-related diabetes.